Study protocol for the health economic evaluation of outpatient long-term video EEGs for people with seizure disorders alongside the ALVEEG study – a randomized controlled equivalence trial

Table 3 Considered costs for the health economic evaluation of the ALVEEG study

Cost category	Costs considered	CG	IG	Data source
Claims data delivered by the participating health insurance companies				Health insurance claims data*
Direct costs
Medical costs	Inpatient services	X	X
	Outpatient services	X	X
	Prescriptions for drugs	X	X
	Therapeutic appliances	X	X
	Assistive devices	X	X
Non-medical costs	Patient transport services	X	X
Indirect costs	Sickness leave benefits	X	X
Investment costs	Outpatient long-term video-EEG devices (ALVEEGs)		X	Provided by manufacturer
Maintenance costs	Costs arising due to maintenance services for the ALVEEGs		X	Provided by manufacturer
Operating costs	Costs for training related to the usage of ALVEEGs per time spent		X	Tariff contracts, surveys
Operating costs	Staff costs for the practical application of ALVEEGs in clinical practice		X	Tariff contracts, surveys

CG Control group, IG Intervention group
*Participating health insurance companies: BARMER, DAK-Gesundheit, and Techniker Krankenkasse

ISSN: 1472-6963